Drug therapy for prevention of recurrent myocardial infarction (Q28165520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Drug therapy for prevention of recurrent myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

main subject

myocardial infarction

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Menno E van der Elst

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Henk Buurma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Anthonius de Boer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1465-1477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

19 December 2019

cites work

1 reference

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 April 2017

1 reference

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

21 April 2017

1 reference

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

21 April 2017

1 reference

Warfarin, aspirin, or both after myocardial infarction

21 April 2017

1 reference

Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study

21 April 2017

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 April 2017

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 April 2017

1 reference

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

21 April 2017

1 reference

Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction

21 April 2017

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 April 2017

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 April 2017

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 April 2017

1 reference

Secondary prevention in acute myocardial infarction

21 April 2017

1 reference

Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable population.

21 January 2018

1 reference

Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

21 January 2018

1 reference

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

21 January 2018

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

21 January 2018

1 reference

Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study)

21 January 2018

1 reference

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.

21 January 2018

1 reference

Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.

21 January 2018

1 reference

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

21 January 2018

1 reference

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

Efficacy of acebutolol after acute myocardial infarction (the APSI trial). The APSI Investigators

21 January 2018

1 reference

Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.

21 January 2018

1 reference

Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study

21 January 2018

1 reference

Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction

21 January 2018

1 reference

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

21 January 2018

1 reference

Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study

21 January 2018

1 reference

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

21 January 2018

1 reference

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14519050%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference